Home › NCT07225660
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
A Randomized Blinded Controlled Trial Assessing Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
Who can join
Ages 18 to 40 · Women
Full eligibility criteria
Inclusion Criteria: 1. Ovary-bearing individuals 18 to 40 years of age. 2. BMI \< 40 kg/m2 3. Non-smoker for at least 3 months prior to study enrollment. Exclusion Criteria: 1. BMI greater than or equal to 40 kg/m2 2. Current Smoker 3. Any contraindications to ovarian stimulation or outpatient egg retrieval under anesthesia
About the study
HOLIDAY is a two-arm, parallel-group, multi-center, randomized trial in which subjects undergoing planned oocyte cryopreservation will be randomized to receive either a 2-month pause of Combined Hormonal Contraceptives (CHC) or immediate start (without a pause).
What is being tested
- OCP pause (other)
Sponsor: Shady Grove Fertility Reproductive Science Center · Participants: 394 · Started: Feb 25, 2026
Contact the study team
- Tasha Newsome, Clinical Research Supervisor · Phone: 301-545-1289
- Seth J Barishansky, MD · Phone: 475-267-9469
Official record on ClinicalTrials.gov — NCT07225660
Locations in the U.S.
| Connecticut | Yale Fertility Center, Orange |
| Maryland | Shady Grove Fertility Rockville, Rockville |
| New York | Reproductive Medicine Associates of New York, New York (Not yet recruiting) |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.